NIH-funded research P01 program project

Understanding how trained immunity affects kidney transplant patients

Official title: Elucidating the role of trained immunity in kidney transplant patients

Funded at Icahn School of Medicine at Mount Sinai · NIH-11064093 · Data updated 2026-11-12

This study is looking at how the immune system's memory affects kidney transplant patients, hoping to find ways to help their bodies accept the new kidney better and improve their overall health after the transplant.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$323,380
NIH project number5P01AI168258-03
Project IDNIH-11064093 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have undergone kidney transplantation and are experiencing challenges related to graft rejection.

Less likely to help

Patients who have not received a kidney transplant or those with other unrelated health conditions may not benefit from this research.

What this research studies

This research investigates the role of trained immunity, a form of innate immune memory, in kidney transplant patients. It aims to understand how this immune response can influence graft rejection and long-term transplant success. By analyzing circulating factors and immune cell behavior, the study seeks to identify ways to modulate these responses to improve patient outcomes. The approach includes both preclinical models and clinical data from kidney transplant patients to validate findings.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing kidney transplant rejection and enhancing long-term graft survival.

How similar studies have gone: Preliminary data from similar studies in heart transplantation have shown promising results, indicating that targeting trained immunity may be a viable approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Mulder, Willem — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Mulder, Willem

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.